# Benralizumab Exacerbation Study

> **NCT04102800** · PHASE4 · COMPLETED · sponsor: **NHS Greater Glasgow and Clyde** · enrollment: 157 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Benralizumab

## Key facts

- **NCT ID:** NCT04102800
- **Lead sponsor:** NHS Greater Glasgow and Clyde
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-09-30
- **Primary completion:** 2024-02-22
- **Final completion:** 2024-04-23
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2024-04-25

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04102800

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04102800, "Benralizumab Exacerbation Study". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04102800. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*